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Sm.mmary The role of the retinoblastoma gene (RBI) in human gastric carcinogenesis is yet to be clarified.
We report on the analysis of RB1 structure and protein (pRB) expression in gastric carcinomas using Southern
blotting, Western blotting and immunohistochemistry. The relationship between pRB expression and cell
proliferation was assessed by a proliferation marker (PCNA) in a subset of cases. Non-neoplastic mucosas
were studied, as controls, by the same methodology. We found a close relationship between pRB expression
and PCNA in non-neoplastic mucosas as well as in gastric carcinomas. All tumours were immunohisto-
chemically positive for pRB, although with a variable proportion of non-immunoreactive cells. Carcinomas of
the diffuse type showed absence of pRB expression in a larger proportion of neoplastic cells than carcinomas
of the intestinal type (P<0.05). Analysis ofthe RBI structure using probe p68RS2.0 revealed allelic imbalance
in 29% of informative cases. No homozygous deletions and/or rearrangements were detected with p68RS2.0
and cDNA probes. Western analysis revealed no abnormal patterns of pRB. Our data therefore suggest that
major alterations affecting the RB1 gene are rather infrequent in human gastric carcinomas.
During the last decade there has been an increasing interest
in studying gene molecular alterations that may be related to
neoplastic initiation. One of the best-studied examples of
such cause-effect molecular mechanisms is the mutational
inactivation of the retinoblastoma gene (RBI), an oncosup-
pressor gene mapped to 13ql4.2. RBI inactivation leads to
the development of retinoblastoma, a rare eye tumour of
proliferating retina. For retinoblastoma development, inac-
tivating 'hits' on both RBI alleles must occur in a precursor
cell of the retina (Knudson, 1971; Cavenee et al., 1983; Dryja
et al., 1986; Friend et al., 1986; Fung et al., 1987; Lee et al.,
1987).
Mutational inactivation of RBI occurs frequently in osteo-
sarcomas (Toguchida et al., 1988; Shew et al., 1989) and
soft-tissue sarcomas (Friend et al., 1987; Reissman et al.,
1989), which suggests that RBI plays an important role in
the development of these tumours. RBI inactivation has been
observed in other malignant tumours, namely cancers of the
breast (Lee et al., 1988; Varley et al., 1989), bladder
(Horowitz et al., 1989; Ishikawa et al., 1991; Cairns et al.,
1991), prostate (Bookstein et al., 1990) and lung (Harbour et
al., 1988; Yokota et al., 1988; Hensel et al., 1990), as well as
in several types of leukaemia (Furukawa et al., 1991). It is
-unlikely that RBI inactivation is a crucial step in the de-
velopment of these tumours as only a proportion of them
have RBI abnormalities.
To our knowledge, gastric cancer has not yet been evalu-
ated for RBI alterations, although loss of heterozygosity for
chromosome 13 had been reported in some gastric car-
cinomas (Motomura et al., 1988; Wada et al., 1988).
We report on the analysis, using immunohistochemistry,
Western blotting and Southern blotting, of the structure and
expression of RBI in human gastric carcinomas comparing
the results obtained with the clinicopathological features and
proliferation activity of the tumours.
Materials and methods
We analysed, using immunohistochemistry (n = 46), Western
blotting (n = 12) and Southern blotting (n = 41), a series of
gastric carcinomas obtained from consecutive surgical resec-
tions performed at Hospital S. Joao, Porto, Portugal.
Matched mucosas (adjacent to and/or distant from the car-
cinomas) were also analysed by the same methodologies.
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Detailed clinical and histopathological data of all patients
and tumours were available (Table I).
The relationship between pRB immunoreactivity and a cell
proliferation marker in gastric carcinomas and corresponding
normal mucosas, as determined by PCNA immunoreactivity
in serial frozen sections, was studied in a subset of cases.
Flow cytometry data (e.g. DNA ploidy, DNA index, pro-
liferative index and S-phase fraction) from some cases of the
present series were already available (David et al., 1994) and
used to correlate pRB expression to proliferation.
Immunohistochemistry,
Several serial cryostat sections (6pm) were obtained from
each sample, stored at -70°C, and used for immunoreac-
tivity studies with pRB and PCNA monoclonal
antibodies.
RB protein Gastric carcinomas and matched mucosas were
analysed with two monoclonal antibodies (PMG3-245 and
NCL-RB) with recognised affinity for the RB1 gene product
(De Caprio et al., 1988; Birtek et al., 1992).
Frozen sections from a poorly differentiated sporadic
retinoblastoma, obtained from the left eye of a 3-year-old
boy, were used as negative biological controls:
1. PMG3-245 (PharMingen, San Diego, CA, USA). Sec-
tions from 46 tumours (46 primary gastric carcinomas and
two lymph node metastases) and 30 mucosas were air dried
overnight, fixed in 4% buffered formalin for 10 min at room
temperature and incubated overnight at 4'C with PMG3-245,
diluted 1:800.
2. NCL-RB (Novo Castra Laboratories Ltd, Newcastle
upon Tyne, UK). Immunohistochemical analysis was per-
formed with this antibody on sections from 15 primary gas-
tric carcinomas and six mucosas. Slides were air dried and
fixed in Zamboni's mixture for 10 min. The primary antibody
was incubated at a concentration of 1:50 for 60 min at room
temperature.
Cell proliferation marker (PCIO, Dako, Denmark). Immuno-
histochemical analysis was performed with this antibody on
sections from 30 primary gastric carcinomas and six
mucosas. Slides were fixed in 4% buffered formalin for 2 min
followed immediately by 10 min in ethanol. PCIO antibody
was diluted 1:600 for 60min.
For all antibodies the antigen-antibody complex was
detected by the avidin-biotin-peroxidase technique (Hsu et
al., 1981), with diaminobenzidine as final chromogen and
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Table I Clinicopathological features of the 46 patients with gastnrc
carcinoma
n %
Sex
Male 28 60.9
Female 18 39.1
Age (years ± s.d.) 62.7 ± 10.8
Tumour site
Antrum 27 58.7
Body 9 19.6
Cardia/fundus 9 19.6
Gastric stump 1 2.1
Histological classification'
Intestinal 21 45.7
Diffuse 12 26.1
Atypical 13 28.2
Wall penetration
Tim (mucosa) 1 2.2
TIsm (submucosa) 2 4.4
T2 (muscular) 8 17.4
T3 (subserosa) 29 63.0
T4a (beyond serosa) 4 8.7
T4b (adjacent organs) 2 4.3
Nodal metastases
NO 19 41.3
N + 27 58.7
Vascular invasion
Mo 18 39.1
Mo vi (venous invasion) 27 58.7
Ml (liver metastasis) 1 2.2
aAccording to Laurein (1965).
haematoxylin as nuclear counterstain. Negative controls were
performed using a mouse myeloma protein of the same sub-
class and concentration.
RBI protein expression and PCNA were independently
evaluated by two pathologists, and semiquantitatively scored
as follows: - (less than 10% immunoreactive cells), +
(10-50% immunoreactive cells) and + + (51-100% of
immunoreactive cells).
Western analvsis
Total protein was extracted from 12 primary gastric car-
cinomas and two normal mucosas (distant from the
tumours). Briefly, fresh tissue was sonicated in ice-cold
sample buffer (Tris 0.5 M pH 6.8, 2% SDS, 10% glycerol and
5% mercaptoethanol). Proteins were separated by 6%
SDS-PAGE and electroblotted to nitrocellulose (Schleicher
& Schuell) membranes. Membranes were incubated with
NCL-RB antibody at the final concentration of 2.5 gg ml-
for 120 min. Colour development was performed using a
streptavidin, biotin, alkaline phosphatase system (RPN22,
Amersham) in accordance with the manufacturer's recom-
mendations.
Total protein extracted from a retinoblastoma-derived cell
line (WERI-RB-1) and from a neuroblastoma cell line (IMR-
32) was used as a negative and positive control respectively
(Figure 1).
Southern analysis
High molecular weight DNA was extracted according to
standard procedures (Mullenbach et al., 1989) from 41
primary gastric carcinomas and mucosas distant from the
tumours. For these studies, we used the frozen blocks of the
tumours processed for pRB and PCNA immunohistochemis-
try.
Microscopic examination of the tissues was carried out to
evaluate contamination by non-neoplastic cells. Following
A B C D
200 kDa -
116 kDa-
97 kDa -
Fugwe 1 Western blot analysis ofpRB in a gastric carcinoma of
the intestinal type (lane C, case 28) and matched mucosa (lane
D). A neuroblastoma cell line, IMR-32 (lane A), was used as
positive control and a retinoblastoma cell line, WERI-RB-1 (lane
B), as negative control. Bands 110 and 116 correspond to the
unphosphorylated and phosphorylated forms of pRB respec-
tively. The smearing pattern seen in lane A is due to different
degrees of phosphorylation status of the cycling cells.
this evaluation, tumour areas containing a high proportion of
non-neoplastic cells were removed from the frozen block with
a scalpel. The remaining neoplastic tissue, always with less
than 50% contaminating non-neoplastic cells, was then used
for DNA extraction.
DNA samples (15ILg) from tumour and normal gastric
mucosa from each patient were digested with several restric-
tion enzymes, subjected to agarose gel electrophoresis (0.8%
or 1.5%) and transferred to nylon membranes by alkaline
blotting.
Genomic probes p68RS2.0 and pI23Ml.8, as well as RBI
cDNA probes pG3.8M and pGH2 0.6 were used to analyse
RB1 gene alterations in all cases. Probe p68RS2.0 detects a
variable number of tandem repeats (VNTRs) within the large
intron between exons 17 and 18 of the RB1 gene (Wiggs et
al., 1988). Probe pI23Ml.8 is located upstream of exon 1
(Blanquet et al., 1991) and was used to detect exons 1 and 2
in DNA samples digested with Sacl. cDNA probes pGH2 0.6
and pG3.8M cover exons 3-8 and exons 9-27 respectively
(Fung et al., 1987).
DNA samples with altered patterns for probe p68RS2.0
were further screened with probe p123Ml.8 detecting a
BanHI polymorphism.
The 1.2 kb BglII/Hind -3'BCR (22q11) probe provided a
reference for equal loading of DNA.
The probes were labelled by primer extension (Feinberg et
al., 1983). Autoradiograms were examined after 2-7 days'
exposure at -70'C.
All bands from the autoradiograms were scored visually
against the control probe. Dosimetric analysis of the intensity
of the hybridisation signals, in cases where changes were
visually detected, was accomplished by automated scanning
densitometry (LKB Gelscan XL).
Statisticalantalysis
Kappa statistics was performed as a measure of inter-
observer agreement. Kappa (K) values above 0.75 reflect
excellent agreement and scores between 0.60 and 0.75 reflect
good agreement (Landis et al., 1977).
RBI product expression results in gastric carcinomas,
assessed by antibody PMG3-245, were compared with
clinicopathological features and cell proliferation parameters
(flow cytometry data), using the Mann-Whitney U-test and
Fishers' one-tailed exact test, as appropriate.
Statistical analyses were performed after excluding cases of
disagreemnt between observers. P-values <0.05 were con-
sidered significantly different.1020 M. CONSTANCIA et al.
Results
Table II summarises the results of the immunohistochemical
and Western studies in 46 patients with gastric carcinomas.
No pRB immunoreactivity was detected in frozen sections of
a sporadic retinoblastoma used as biological negative con-
trol.
Immunohistochemical analyses
Gastric mucosas PMG3-245 antibody immunoreactivity re-
vealed high levels of pRB in proliferative areas such as the
neck zone of the glands and crypts of intestinal metaplasia.
Low or absent expression was detected in non-proliferative
areas such as the foveolar epithelium and normal mucous
glands. Gastric lesions such as dysplasia and foveolar
hyperplasia displayed immunoreactivity. The NCL-RB
antibody yielded similar results to the PMG3-245
antibody.
PCNA immunoreactivity revealed a topographic correla-
tion with pRB expression, on serial frozen sections.
Table I Summary of pRB and PCNA in
findings in primary
Gastric carcinomas A good agreement between the two
pathologists was observed in respect of pRB/PMG3-245
immunoreactivity scores (x = 0.66). Excellent agreement was
attained for PC1O immunoreactivity scores (x =0.92).
The comparison between immunoreactivity scores for the
two pRB antibodies in 15 cases where both antibodies
(PMG3-245 and NCL-RB) were used revealed no significant
differences.
All carcinomas, as well as two lymph node metastases,
were immunoreactive for pRB (Figure 2). The majority
(88%) scored as + + (51-100% stained cells) (Table H).
The percentage of intestinal carcinomas displaying high
(+ +) pRB immunoreactivity (100%) was significantly higher
(P<0.05) than that of diffuse carcinomas (70%) (Table III)
and non-significantly higher than that of atypical carcinomas
(80%). No other significant associations were found between
loss of pRB immunoreactivity and the clinicopathological
features presented in Table I.
The percentage of intestinal carcinomas displaying a high
score of PCNA immunoreactivity (100%) was significantly
higher (P<0.001) than that of intestinal carcinomas (11I%),
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and non-significantly higher than that of atypical carcinomas
(86%).
When assessed in paired samples there is total concordance
of pRB and PCNA immunoreactive scores in intestinal car-
cinomas and a fairly high concordance in atypical car-
cinomas. The same does not hold true for diffuse carcinomas,
which displayed low PCNA scores regardless of the pRB
score.
Western analysis
The 12 tumours analysed by Western blotting revealed nor-
mal patterns (MW 110 kDa) of pRB (Figure 1), except for
patients 28 (Figure 1) and 33, in whom no phosphorylated
forms of pRB were detected using this method.
i.
.P
Figwe 2 Immunoreactivity for pRB in patient no. 7 (diffuse,
signet-ring cell type carcinoma), showing an evident nuclear stain-
ing pattern (PMG3-245) (x 420).
Table m pRB and PCNA immunoreactivity scores in carcinomas
of the intestinal and diffuse types
Histological pRBf (n = 31) PCNAb (n = 22)
type + + + + + +
Intestinal 0 (0%) 21 (100%) 0 (0%) 13 (100%)
Diffuse 3 (30%) 7 (70%) 8 (89%) 1 (11%)
aTwocasesexcudedowing tointer-observrdisagremnt; P = 0.027
(Fisher's exact test). bOne case exchlded owing to inter-obsrVer
disagreement, P = 0.00003 (Fisher's exact test). Scores: +, 10-50%
stained cells; + +, 51-100% stained cells.
Southern analysis
Probe p68RS2.0 was used to screen 41 DNA pairs of tumour
and normal mucosas. Allelic imbalance was found in 5 (29%)
of 17 informative cases (patients 4, 16, 28, 30 and 36) (Figure
3). In two of these five cases a total loss of one allele in
tumour DNA was detected (patients 16 and 36) (Figure 3).
Duplication of both alleles was found in one tumour (patient
3) (Figure 3). In order to confirm and extend the data to the
coding regions of the RBI gene, all DNA samples were
reprobed using cDNA probes. No homozygous deletions
and/or rearrangements were detected using VNTR and
cDNA probes. Patients 3, 4 and 16, in whom gene dosage
alterations were detected with probe p68RS2.0, also showed
different intensity signals with cDNA probes in tumour DNA
compared with corresponding normal mucosas (Table IV). In
the remaining cases no differences in intensity of the cDNA
RBI hybridisation signals of tumour and normal mucosas
were detected when compared with chromosome 22 control
probe.
Results with probe pl23M1.8/BanHl revealed that the
alterations detected in three cases (patients 28, 30 and 36)
started within the RBI gene (Table IV).
Table IV summarises the Southern analysis results of the
cases with alterations affecting RBI.
All patients showing alterations within the RBI gene had
advanced-stage tumours (Table IV).
All tumours with allelic imbalance for the RBI locus were
immunohistochemically scored as + + (51-100%
immunoreactive cells), with the exception of tumours from
patient 36 (scored as +: 10-50% immunoreactive cells)
(Table IV).
We found a close relationship between pRB immunoreac-
tivity and cell proliferation (PCNA) in non-neoplastic gastric
mucosas. Accordingly, pRB immunoreactivity was high in
proliferative areas and low or absent in non-proliferating
areas. Our findings and the recent demonstration of signifi-
cant pRB nuclear staining in cells of normal adult intestinal
crypts with absent nuclear staining in the epithelial cells of
the vili (Xu et al., 1991), as well as in germinal centres of
reactive lymph nodes (Martinez et al., 1993), support the
contention that pRB expression is cell cycle associated.
RBI protein immunoreactivity was found in- all primary
gastric carcinomas analysed, and in the two lymph node
metastases. In our study a semiquantitative scoring system
p68RS2.0
kb
1.85-
1.5 _
N T N T N T N T N T N T
A B C D E F
3 BCR
Fge 3 Southern analyses of Rsal-digested genomic DNA from gastnc carcinoma tissue samples (T) and matched mucosas (N)
in cases with RBI gene alterations. A (patient 3), duplication of both alleles in tumour DNA; B, C, D, E, F (patients 4, 16, 28, 30
and 36 respectively), allelic imbalance (Al). In patients 16 and 36 (C and F) a total klss of one allele on tumour DNA was detected.
All filters have been hybridised to the VNTR probe p68RS2.0, and rehybridised with 3'BCR probe for DNA loading cont-
rol.1022 M. CONSTANCIA et al.
Table IV Results of the Southern analysis of the cases with RB1 alterations
p123ML.8 p68RS2.0 pG3.8M
Cases Histolog) Stage BamHI RsaI HindIII pRB score
3 Intestinal T3 +/Dupl. +/Dupl. 2 x * *
4 Diffuse T3 - +AI 16 x
16 Atypical T4a +/LOH +/LOH 0.5x * *
28 Intestinal T3 + +AI **
30 Intestinal T2 + +AI **
36 Atypical T3 + +/LOH *
+ Heterozygosity in normal and tumour DNA; - constitutional homozygosity; Dupl, duplication
of both alleles in tumour DNA; LOH, loss ofheterozygosity in tumour DNA; Al, allelic imbalance;
x, number of times of difference measured in tumour compared with normal sample; *, 10-50%
stained cells; **, 51-100% stained cells.
was used to evaluate pRB immunoreactivity, thus minimising
the effects of tumour heterogeneity. In the majonrty of cases
we observed staining in more than 50% of neoplastic cells. In
all cases, therefore, a variable proportion of non-pRB
immunoreactive neoplastic cells was noted. This finding can
be due to low levels of pRB escaping detection by immuno-
histochemistry (a normal phenomenon during the Go/middle
GI phases of the cell cycle: Xu et al., 1991; Martinez et al.,
1993), or to functional or structural abnormalities of the
gene. Both possibilities are indistinguishable at the single-cell
level. Owing to the cell cycle-dependent expression of pRB a
study of the proliferation status of the tumours was therefore
conducted.
In gastric carcinomas of the diffuse type we observed
significantly lower amounts of pRB and of PCNA than in
intestinal and atypical carcinomas. Since previous reports
(Saitoh et al., 1992; David et al., 1994) have shown that
carcinomas of the diffuse type are less proliferative than
intestinal-type carcinomas, our data suggest, although
indirectly, that pRB immunoreactivity associates with cell
proliferation in gastric cancer. This hypothesis is further
supported by our flow cytometric evaluation of cell prolifera-
tion in these cases, showing a consistent trend (albeit not
statistically significant) between cell proliferative indexes and
pRB immunoreactivity scores (data not shown).
It is important to note, however, that PCNA scores prob-
ably overestimate the number of proliferative cells, since
PCNA is detected in a very high percentage ofcells. Previous
reports (Hall et al., 1990; Rosa et al., 1992) suggest that
PCNA immunoreactivity may be detected in cancer cells that
have recently left the cycle owing to the long half-life of the
antigen or to alteration of mRNA stability induced by
growth factors.
It is tempting to speculate that the same or other
epigenetic mechanisms affect pRB expression in gastric car-
cinomas, as a close relation was found between pRB and
PCNA immunoreactivities. Alternatively, pRB may be identi-
fying cell populations in earlier phases of the cell cycle than
those identified by PCNA. This hypothesis would explain the
cases in which higher immunoreactive scores were observed
for pRB than for PCNA.
Western blot analysis revealed normal patterns in the 12
primary gastric carcinomas studied, thus excluding gross
changes in pRB. The absence of phosphorylated forms in
'normal' mucosas is a previously well-documented pheno-
menon (Xu et al., 1991) and occurs because the proliferative
fraction (neck zone of the glands) is rather small when
compared with the total number of cells and, therefore,
undetectable by the technique used. The same explanation
and/or stromal contamination may explain the absence of
phosphorylated bands in the tumours.
The few studies published on chromosomal abnormalities
in stomach cancer using cytogenetic analysis (Ochi et al.,
1986; Ferti-Passantonopoulou et al., 1987; Seruca et al.,
1993) report, almost unanimously, that chromosome 13 is
one of the most common chromosomes affected in these type
of tumours. Studies conducted in order to establish the fre-
quency of allele losses on chromosome 13 in primary gastric
cancers, reported by Motomura et al. (1988) and Wada et al.
(1988), revealed loss of heterozygosity in 41% and 11% of
informative cases respectively. None of these studies, how-
ever, was designed to evaluate directly the allelic loss within
the retinoblastoma gene.
In our study RB1 structure was checked by Southern
blotting, using two genomic probes, and two cDNA probes
in the 41 cases of gastric carcinomas. No obvious RB1
rearrangement or homozygous deletions were detected.
Allelic imbalance was found in 29% of informative cases.
Total loss of one allele was seen in two of the five cases
showing allelic imbalance, thus suggesting that in a minor
proportion of cases the RB1 gene may be important for the
oncogenesis and/or progression of these tumours. On the
other hand, the true nature of the remaining cases showing
allelic imbalance is difficult to ascertain. They may be due to
the result of clonal variation in RB1 copy number (duplica-
tion or loss) and/or stromal contamination.
In one case duplication of both alleles was detected.
Monosomy of the chromosome 22 control probe was ex-
cluded since the filters were rehybridised with other VNTR
probes (for chromosomes 6 and 17) and an equal loading in
the normal and tumour lanes was confirmed. This finding is
probably the result of an increase in chromosome copy
number (tetrasomy) as duplication of both tumour alleles
was also seen with a telomeric probe (p9A7) (data not
shown).
In three cases (28, 30 and 36), all showing alterations with
probe p68RS2.0, the 5.4 and 7.5 kb pG3.8M/HindIII
fragments flank-ing this intronic region showed no change in
intensity signal when compared with normal mucosa frag-
ments. These findings are therefore suggestive that alterations
were confined to this intronic region, which is keeping with
the suggestion that the DNA sequence detected by probe
p68RS2.0 might contain hotspots for structural aberrations
(T'Ang et al., 1989). Further studies are, however, required
to confirm these findings.
It is noteworthy that no clear correlation was found
between molecular alterations and loss of pRB immunoreac-
tivity in our series. Similar findings have been described for
other tumours in which RBI allelic loss was not accompanied
by loss of immunoreactivity (Ishikawa et al., 1991; Borg et
al., 1992). Loss of pRB immunoreactivity also did not cor-
relate with clinicopathological features such as tumour site,
tumour staging, vascular invasion, nodal metastases, etc.
In summuary, our results suggest that RB1 does not play,
by itself, a crucial role in the oncogenesis of human gastric
carcinomas. This contention is based on the following obser-
vations: pRB expression was found in all gastric carcinomas
analysed and is associated with the proliferation status of the
tumours; pRB protein, as assessed by Western blotting,
showed normal patterns (110-116 kDa); loss of heterozy-
gosity is not a frequent event and gross alterations such as
homozygous deletions and or rearrangements were undetec-
table.
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